These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
731 related articles for article (PubMed ID: 28122302)
21. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related]
22. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery. Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310 [TBL] [Abstract][Full Text] [Related]
23. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo. Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874 [TBL] [Abstract][Full Text] [Related]
24. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery. Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098 [TBL] [Abstract][Full Text] [Related]
25. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment. Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415 [TBL] [Abstract][Full Text] [Related]
26. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue. Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349 [TBL] [Abstract][Full Text] [Related]
27. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy. Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854 [TBL] [Abstract][Full Text] [Related]
28. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829 [TBL] [Abstract][Full Text] [Related]
29. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model. Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445 [TBL] [Abstract][Full Text] [Related]
30. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology. Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653 [No Abstract] [Full Text] [Related]
31. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy. Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562 [TBL] [Abstract][Full Text] [Related]
32. TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA. Dong S; Zhou X; Yang J Biomed Pharmacother; 2016 Dec; 84():954-961. PubMed ID: 27764758 [TBL] [Abstract][Full Text] [Related]
33. Preparation of Engineered Salmonella Typhimurium-Driven Hyaluronic-Acid-Based Microbeads with Both Chemotactic and Biological Targeting Towards Breast Cancer Cells for Enhanced Anticancer Therapy. Uthaman S; Zheng S; Han J; Choi YJ; Cho S; Nguyen VD; Park JO; Park SH; Min JJ; Park S; Park IK Adv Healthc Mater; 2016 Jan; 5(2):288-95. PubMed ID: 26584018 [TBL] [Abstract][Full Text] [Related]
34. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging. Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021 [TBL] [Abstract][Full Text] [Related]
35. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer. Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634 [TBL] [Abstract][Full Text] [Related]
36. Targeted Imaging and Chemo-Phototherapy of Brain Cancer by a Multifunctional Drug Delivery System. Hao Y; Wang L; Zhao Y; Meng D; Li D; Li H; Zhang B; Shi J; Zhang H; Zhang Z; Zhang Y Macromol Biosci; 2015 Nov; 15(11):1571-85. PubMed ID: 26171594 [TBL] [Abstract][Full Text] [Related]
37. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
38. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738 [TBL] [Abstract][Full Text] [Related]
39. Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway. Wang Y; Li J; Chen JJ; Gao X; Huang Z; Shen Q Mol Pharm; 2017 Apr; 14(4):1120-1132. PubMed ID: 28291364 [TBL] [Abstract][Full Text] [Related]
40. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]